Founded in 1984 by brothers Steven and Mitchell Rales and headquartered in Washington, D.C., Danaher Corporation has developed into a leading global life sciences and diagnostics innovator, built around a disciplined operating model and a long record of strategic portfolio development. Today, the company is focused on biotechnology, life sciences, and diagnostics, supporting customers across research, biopharmaceutical development, and clinical testing through a portfolio that includes businesses such as Cytiva, Beckman Coulter, Cepheid, Leica, Pall, and SCIEX. Danaher operates in 50 countries and 700 locations worldwide, and in 2025 it reported revenue of $24.6 billion and described its global workforce as approximately 60,000 associates, reflecting the scale of a business dedicated to advancing science and improving human health.
Updated 2026-03-19